Metropolitan Medical partners with Spacelabs Healthcare to offer Spacelabs’ BleaseSirius Anesthesia System

Metropolitan Medical — a premiere anesthesia sales and service supplier — now offers a new anesthesia delivery and ventilation system from Spacelabs Healthcare.

Asheville, NC.  Metropolitan Medical and Spacelabs Healthcare announced today a distributorship that provides customers in six states the opportunity to purchase new, high-quality anesthesia delivery and ventilation systems, manufactured in the U.S. The partnership allows MMS to sell the BleaseSirius anesthesia delivery system in Florida, Mississippi, Alabama, Georgia, Tennessee, and to certain accounts near Asheville, North Carolina.

Spacelabs Healthcare, Inc., is a manufacturer of medical equipment for the global healthcare market, offering over 50 years of trusted clinical partnership. Their legacy began with a contract to work on the Gemini space program in 1958 with NASA. In 2006, Spacelabs Healthcare purchased Blease Medical, a UK-based company that had been manufacturing anesthesia delivery machines and ventilators for over 60 years. Spacelabs’ anesthesia delivery systems are manufactured in Issaquah, Washington.

“Spacelabs Anesthesia Systems, including the new BleaseSirius, incorporate the latest technology offering clinicians unparalleled performance in ventilation and vaporization,” said Joe Davin, Group President, Spacelabs Healthcare. “Focusing on the patient and clinician to machine relationship has allowed us to offer clinicians integrated technology, reduced cost of ownership and clinical ease of use.”

Metropolitan Medical has been a leading supplier of new and refurbished anesthesia equipment and service in the U.S for over 15 years. Metropolitan is dedicated to 100% customer satisfaction, and offers a complete portfolio of solutions for your anesthesia needs.

“With this relationship, we’re now providing our customers with the option to purchase new anesthesia machines, with state-of-the-art ventilation technology at a value price point,” said Jeff Rhinehart, CEO, Metropolitan Medical Services.